213 related articles for article (PubMed ID: 29986700)
1. Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.
Syn NL; Wong AL; Lee SC; Teoh HL; Yip JWL; Seet RC; Yeo WT; Kristanto W; Bee PC; Poon LM; Marban P; Wu TS; Winther MD; Brunham LR; Soong R; Tai BC; Goh BC
BMC Med; 2018 Jul; 16(1):104. PubMed ID: 29986700
[TBL] [Abstract][Full Text] [Related]
2. Chinese Patients With Heart Valve Replacement Do Not Benefit From Warfarin Pharmacogenetic Testing on Anticoagulation Outcomes.
Hao Y; Yang J; Zheng X; Hu Y; Yan X; Zhang L
Ther Drug Monit; 2019 Dec; 41(6):748-754. PubMed ID: 31259883
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of genotype-guided dosing of warfarin.
Pirmohamed M; Burnside G; Eriksson N; Jorgensen AL; Toh CH; Nicholson T; Kesteven P; Christersson C; Wahlström B; Stafberg C; Zhang JE; Leathart JB; Kohnke H; Maitland-van der Zee AH; Williamson PR; Daly AK; Avery P; Kamali F; Wadelius M;
N Engl J Med; 2013 Dec; 369(24):2294-303. PubMed ID: 24251363
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial.
Anand A; Hegde NC; Chhabra P; Purohit J; Kumar R; Gupta A; Lad DP; Mohindra R; Mehrotra S; Vijayvergiya R; Kumar B; Sharma V; Malhotra P; Ahluwalia J; Das R; Patil AN; Shafiq N; Malhotra S
Ann Hematol; 2024 Jun; 103(6):2133-2144. PubMed ID: 38634917
[TBL] [Abstract][Full Text] [Related]
5. A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Kimmel SE; French B; Kasner SE; Johnson JA; Anderson JL; Gage BF; Rosenberg YD; Eby CS; Madigan RA; McBane RB; Abdel-Rahman SZ; Stevens SM; Yale S; Mohler ER; Fang MC; Shah V; Horenstein RB; Limdi NA; Muldowney JA; Gujral J; Delafontaine P; Desnick RJ; Ortel TL; Billett HH; Pendleton RC; Geller NL; Halperin JL; Goldhaber SZ; Caldwell MD; Califf RM; Ellenberg JH;
N Engl J Med; 2013 Dec; 369(24):2283-93. PubMed ID: 24251361
[TBL] [Abstract][Full Text] [Related]
6. Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.
Guo C; Kuang Y; Zhou H; Yuan H; Pei Q; Li J; Jiang W; Ng CM; Chen X; Huo Y; Cui Y; Wang X; Yu J; Sun X; Yu W; Chen P; Miao D; Liu W; Yu Z; Ouyang Z; Shi X; Lv C; Peng Z; Xiong G; Zeng G; Zeng J; Dai H; Peng J; Zhang Y; Xu F; Wu J; Chen X; Gong H; Yang Z; Wu X; Fang Q; Yang L; Li H; Tan H; Huang Z; Tang X; Yang Q; Tu S; Wang X; Xiang Y; Huang J; Wang X; Cai J; Jiang S; Huang L; Peng J; Gong L; Zou C; Yang G
Circ Genom Precis Med; 2020 Aug; 13(4):e002602. PubMed ID: 32510984
[TBL] [Abstract][Full Text] [Related]
7. Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
Limdi NA; Wiener H; Goldstein JA; Acton RT; Beasley TM
Blood Cells Mol Dis; 2009; 43(1):119-28. PubMed ID: 19297219
[TBL] [Abstract][Full Text] [Related]
8. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
[TBL] [Abstract][Full Text] [Related]
10. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
11. Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.
Makar-Aušperger K; Krželj K; Lovrić Benčić M; Radačić Aumiler M; Erdeljić Turk V; Božina N
Ther Drug Monit; 2018 Jun; 40(3):362-368. PubMed ID: 29494423
[TBL] [Abstract][Full Text] [Related]
12. Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials.
Tse G; Gong M; Li G; Wong SH; Wu WKK; Wong WT; Roever L; Lee APW; Lip GYH; Wong MCS; Liu T;
Br J Clin Pharmacol; 2018 Sep; 84(9):1868-1882. PubMed ID: 29704269
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of randomized controlled trials reveals an improved clinical outcome of using genotype plus clinical algorithm for warfarin dosing.
Liao Z; Feng S; Ling P; Zhang G
J Thromb Thrombolysis; 2015 Feb; 39(2):228-34. PubMed ID: 24962733
[TBL] [Abstract][Full Text] [Related]
15. A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional.
Sridharan K; Sivaramakrishnan G
J Clin Pharm Ther; 2021 Jun; 46(3):640-648. PubMed ID: 33346393
[TBL] [Abstract][Full Text] [Related]
16. Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study.
McMillin GA; Melis R; Wilson A; Strong MB; Wanner NA; Vinik RG; Peters CL; Pendleton RC
Ther Drug Monit; 2010 Jun; 32(3):338-45. PubMed ID: 20386359
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.
Arwood MJ; Deng J; Drozda K; Pugach O; Nutescu EA; Schmidt S; Duarte JD; Cavallari LH
Clin Pharmacol Ther; 2017 May; 101(5):675-683. PubMed ID: 28032893
[TBL] [Abstract][Full Text] [Related]
18. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
[TBL] [Abstract][Full Text] [Related]
19. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
[TBL] [Abstract][Full Text] [Related]
20. Genotype-Guided Warfarin Dosing in Patients With Mechanical Valves: A Randomized Controlled Trial.
Xu Z; Zhang SY; Huang M; Hu R; Li JL; Cen HJ; Wang ZP; Ou JS; Yin SL; Xu YQ; Wu ZK; Zhang X
Ann Thorac Surg; 2018 Dec; 106(6):1774-1781. PubMed ID: 30205115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
